APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $29.7M invested in Aptevo Therapeutics in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.75M
2
+$2.53M
3
+$2.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.14M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.27M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$254K
27
$253K
28
$233K
29
$222K
30
$192K
31
$168K
32
$157K
33
$157K
34
$155K
35
$143K
36
$131K
37
$122K
38
$120K
39
$111K
40
$111K
41
$110K
42
$99K
43
$94K
44
$90K
45
$87K
46
$86K
47
$69K
48
$64K
49
$63K
50
$60K
1
2
3 4